4//SEC Filing
Burkoth William T. 4
Accession 0001209191-18-035383
CIK 0001645113other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 8:12 PM ET
Size
8.0 KB
Accession
0001209191-18-035383
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Burkoth William T.
Director
Transactions
- Award
Options to Buy Ordinary Shares
2018-05-31+12,345→ 12,345 totalExercise: $31.45Exp: 2028-05-31→ Ordinary Shares (12,345 underlying) - Award
Restricted Stock Unit
2018-05-31+6,145→ 6,145 total→ Ordinary Shares (6,145 underlying)
Footnotes (3)
- [F1]Options to buy 12,345 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share.
- [F3]These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001654261
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 8:12 PM ET
- Size
- 8.0 KB